QuantLogix ← ABBV scorecard
📅 ABBV Earnings Preview
ABBVIE INC.
Next report (est.)
September 22, 2026
Countdown
101 days
EPS growth YoY
-45.8%
Revenue growth YoY
+12.4%
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
May 8, 2026 ±2.1% -0.6% over-priced
November 4, 2025 ±3.0% +1.9% over-priced
August 4, 2025 ±3.3% +1.0% over-priced
May 9, 2025 ±3.2% -0.5% over-priced
November 4, 2024 ±2.7% -1.5% over-priced
August 7, 2024 ±3.0% +1.0% over-priced
May 3, 2024 ±2.9% +1.9% over-priced
November 6, 2023 ±2.6% -0.2% over-priced
Across these reports, options implied an average ±2.8% move vs an actual average of 1.1% — the stock stayed inside the implied band 100% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q1 FY2026 $0.39 $15.0B $697M
Q4 FY2025 $1.02 $16.6B $1.8B
Q3 FY2025 $0.10 $15.8B $188M
Q2 FY2025 $0.52 $15.4B $941M
Live 5-factor engine read: Buy · 59/100 Full scorecard →
Get alerted before every ABBV report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on ABBV before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

ABBVIE INC. (ABBV) reports in 101 days, with the next report estimated for September 22, 2026. Across the last 8 reports, options priced an average ±2.8% earnings move while the stock actually moved 1.1% on average — the market has systematically over-priced ABBV's earnings risk. Fundamentals into the print: EPS down 45.8% year-over-year, revenue up 12.4%. QuantLogix's live 5-factor engine currently reads ABBV as a buy at 59/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →